2023
Epinephrine in Cardiac Arrest: Identifying a Potential Limit for Resuscitation
Boivin Z, Duignan K, Doko D, Pugliese N, She T. Epinephrine in Cardiac Arrest: Identifying a Potential Limit for Resuscitation. Western Journal Of Emergency Medicine 2023, 0: 1025-1033. PMID: 38165183, PMCID: PMC10754196, DOI: 10.5811/westjem.60840.Peer-Reviewed Original ResearchConceptsIntact dischargeEpinephrine dosesDose groupEpinephrine usePrimary outcomeCardiac arrestAdvanced cardiac life support algorithmRetrospective cohort studyModified Rankin ScaleFurther prospective studiesDifferent patient subgroupsMedical cardiac arrestNon-shockable rhythmEmergency department administrationEmergency medical servicesLack of evidenceCohort studyRankin ScaleSecondary outcomesIntact survivalMore dosesProspective studyShockable rhythmPatient subgroupsResuscitation efforts
2018
Physical activity barriers, preferences, and beliefs in childhood cancer patients
Ross WL, Le A, Zheng DJ, Mitchell HR, Rotatori J, Li F, Fahey JT, Ness KK, Kadan-Lottick NS. Physical activity barriers, preferences, and beliefs in childhood cancer patients. Supportive Care In Cancer 2018, 26: 2177-2184. PMID: 29383508, DOI: 10.1007/s00520-017-4041-9.Peer-Reviewed Original ResearchConceptsChildhood cancer patientsCancer patientsTherapy patientsActivity barriersPhysical complaintsPediatric hematology-oncology clinicLow physical activity levelsOff-therapy patientsCancer diagnosisMethodsCross-sectional studyHematology-oncology clinicLong-term complicationsBenefits of exerciseDifferent patient subgroupsPhysical activity levelsPhysical activity barriersLeukemia/lymphomaTherapy statusPatient subgroupsExercise barriersPatientsVs. 12TherapyActivity levelsMost respondents
2009
Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung disease
Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP. Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung disease. Arthritis & Rheumatism 2009, 60: 2183-2192. PMID: 19565490, PMCID: PMC2710404, DOI: 10.1002/art.24631.Peer-Reviewed Original ResearchConceptsInterstitial lung diseaseMultiplex enzyme-linked immunosorbent assayUsual interstitial pneumoniaC-reactive proteinAntibody-positive individualsEnzyme-linked immunosorbent assayInterstitial pneumoniaSerum levelsLung diseaseLarge cohortBiomarker assessmentIncidence of ILDMyositis-associated interstitial lung diseaseAnti-Jo-1 antibodyPulmonary function test resultsOpen lung biopsyNonspecific interstitial pneumoniaSerum inflammation markersSubset of patientsElevated serum levelsFunction test resultsIdiopathic pulmonary fibrosisDifferent patient subgroupsComputed tomography scanInducible chemokines CXCL9
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply